Publicaciones (24) Publicaciones de MARIA ESTHER NISTAL GONZÁLEZ

2024

  1. Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

2023

  1. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

    Hepatology, Vol. 77, Núm. 5, pp. 1654-1669

2021

  1. Aging, gut microbiota and metabolic diseases: Management through physical exercise and nutritional interventions

    Nutrients, Vol. 13, Núm. 1, pp. 1-21

  2. Long-term effects of bariatric surgery on gut microbiota composition and faecal metabolome related to obesity remission

    Nutrients, Vol. 13, Núm. 8

  3. The synbiotic combination of akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation

    Antioxidants, Vol. 10, Núm. 12

2020

  1. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children

    Experimental and Molecular Medicine, Vol. 52, Núm. 7, pp. 1048-1061

2019

  1. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease

    Molecular Nutrition and Food Research, Vol. 63, Núm. 20

  2. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 275-282

  3. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

  4. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

    Molecular Nutrition and Food Research, Vol. 63, Núm. 8

2018

  1. Gut microbiota and dysbiosis in the pathogenesis of non-alcoholic fatty liver disease

    Fatty liver disease: a reality with many questions (Eolas), pp. 199-223

  2. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease

    Frontiers in Physiology, Vol. 9

2017

  1. Gluten-degrading bacteria are present in the human small intestine of healthy volunteers and celiac patients

    Research in Microbiology, Vol. 168, Núm. 7, pp. 673-684

  2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation

    Free Radical Biology and Medicine, Vol. 102, pp. 188-202

2016

  1. Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active celiac disease vs non-celiac disease controls

    Journal of Applied Microbiology, Vol. 120, Núm. 6, pp. 1691-1700

2015

  1. Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives

    British Journal of Nutrition, Vol. 114, Núm. 8, pp. 1157-1167

  2. Factors determining colorectal cancer: The role of the intestinal microbiota

    Frontiers in Oncology, Vol. 5, Núm. OCT

2014

  1. Diversity of the cultivable human gut microbiome involved in gluten metabolism: Isolation of microorganisms with potential interest for coeliac disease

    FEMS Microbiology Ecology, Vol. 88, Núm. 2, pp. 309-319

  2. Gluten Metabolism in Humans. Involvement of the Gut Microbiota.

    Wheat and Rice in Disease Prevention and Health (Elsevier Inc.), pp. 157-170

2012

  1. A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity

    European Journal of Nutrition, Vol. 51, Núm. 3, pp. 293-299